Knack Packaging: Submits Q2 FY27 IPO Proceeds Monitoring Report

Knack Packaging Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026. The report, issued by CARE Ratings Limited, details the utilization of proceeds raised through the company’s Initial Public Offer (IPO). The document confirms that the utilization of funds during Q2FY27 aligns with the stated objects of the IPO, with no major deviations noted.

Monitoring Agency Report Submitted for Q2 FY27

Knack Packaging Limited has officially submitted its Monitoring Agency Report for the financial quarter ending September 30, 2026. This report is a regulatory requirement, ensuring transparency in the utilization of funds raised from the company’s Initial Public Offer (IPO).

Key Findings from the Report

The report, prepared by CARE Ratings Limited, acting as the Monitoring Agency, indicates that the utilization of IPO proceeds during the second quarter of the fiscal year 2027 (Q2FY27) is in line with the objects disclosed in the offer document. Specifically, the report details the allocation of funds towards various objectives, including capital expenditure for a new manufacturing facility, general corporate purposes, and issue-related expenses.

For the quarter, a total of ₹56.07 crore was utilized. The primary allocation within this period was for general corporate purposes (₹29.47 crore), followed by offer-related expenses (₹25.90 crore), and a smaller portion for the capital expenditure of the new manufacturing facility (₹0.70 crore).

Status of Funds and Compliance

As of September 30, 2026, the total unutilized amount from the IPO proceeds stands at ₹323.93 crore. The report confirms that there have been no material deviations from the objects for which the funds were raised. The company’s Audit Committee and Board of Directors have reviewed and noted the contents of this report.

The report also outlines the deployment of unutilized proceeds, which include investments in fixed deposits with various banks and a monitoring account. The company’s management confirms that the utilization of funds, particularly for general corporate purposes, is in accordance with board approvals and SEBI ICDR Regulations.

Source: BSE

Previous Article

Hindustan Unilever: Brazilian Subsidiary Voluntarily Liquidated

Next Article

Polycab India: NCLAT Orders MSCI Not to Delist Stock Pending Order